Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
Episodes 1-16 of 115
Charles Turck, PharmD, BCPS, BCCCP
Seema A. Bhat, MD
Joanna Rhodes, MD, MSCE
- Project Oncology®
Personalizing Relapsed/Refractory CLL Care: Key Factors to Consider
Charles Turck, PharmD, BCPS, BCCCP
Lindsey Roeker, MD
- Project Oncology®
Managing B-Cell Lymphomas in the Second-Line Setting: The Role of CAR T-Cell Therapy
Jennifer Caudle, DO
Sarah Rutherford, MD
Charles Turck, PharmD, BCPS, BCCCP
Richard R. Furman, MD
Javier Pinilla, MD, PhD
Charles Turck, PharmD, BCPS, BCCCP
Tara Graff, DO, MS
Charles Turck, PharmD, BCPS, BCCCP
Adam Kittai, MD
- Project Oncology®
The CLL Landscape: A Look at Current and Future Therapies
John Russell, MD
Andrew H. Lipsky, MD
- Project Oncology®
Monitoring Treatment Reponses in CLL: A Review of Key Protocols
Charles Turck, PharmD, BCPS, BCCCP
Lindsey Roeker, MD
- Project Oncology®
CLL Treatment: Managing Uncertainty Through Effective Communication
John C. Byrd, MD
- Project Oncology®
Navigating CLL Treatment: A Deep Dive into Efficacy and Safety
John Russell, MD
Seema A. Bhat, MD
- Project Oncology®
Best Practices for Utilizing Shared Decision-Making in CLL Care
Charles Turck, PharmD, BCPS, BCCCP
Adam Kittai, MD
Matthew Lunning, DO, FACP
- Project Oncology®
AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
- Project Oncology®
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Alan Bryce, MD
Charles Turck, PharmD, BCPS, BCCCP
Neeraj Agarwal, MD, FASCO
Rishi Sekar, MD
- Prev
- Next